BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 143.27 Million USD | -11.43% |
| 2022 | 161.75 Million USD | 35.75% |
| 2021 | 119.15 Million USD | 147.79% |
| 2020 | 48.08 Million USD | 75.69% |
| 2019 | 27.37 Million USD | 38.64% |
| 2018 | 19.74 Million USD | 79.11% |
| 2017 | 11.02 Million USD | 33.97% |
| 2016 | 8.22 Million USD | 27.57% |
| 2015 | 6.44 Million USD | 4.17% |
| 2014 | 6.19 Million USD | -30.83% |
| 2013 | 8.94 Million USD | 58.03% |
| 2012 | 5.66 Million USD | 105.28% |
| 2011 | 2.75 Million USD | 32.53% |
| 2010 | 2.08 Million USD | 31.61% |
| 2009 | 1.58 Million USD | 19.59% |
| 2008 | 1.32 Million USD | 36.02% |
| 2007 | 972.26 Thousand USD | 61.18% |
| 2006 | 603.21 Thousand USD | -1.87% |
| 2005 | 614.71 Thousand USD | -1.91% |
| 2004 | 626.7 Thousand USD | 3.5% |
| 2003 | 605.51 Thousand USD | -28.66% |
| 2002 | 848.79 Thousand USD | -36.85% |
| 2001 | 1.34 Million USD | 12.99% |
| 2000 | 1.18 Million USD | -33.04% |
| 1999 | 1.77 Million USD | -25.03% |
| 1998 | 2.36 Million USD | -33.65% |
| 1997 | 3.57 Million USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 13.59 Million USD | 1.45% |
| 1994 | 13.4 Million USD | 127.12% |
| 1993 | 5.9 Million USD | 5800.0% |
| 1992 | 100 Thousand USD | 0.0% |
| 1991 | 100 Thousand USD | 0.0% |
| 1990 | 100 Thousand USD | 0.0% |
| 1989 | 100 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 31.72 Million USD | -3.07% |
| 2024 Q2 | 28.32 Million USD | -10.71% |
| 2023 Q1 | 37.7 Million USD | -14.81% |
| 2023 FY | 143.27 Million USD | -11.43% |
| 2023 Q2 | 39.5 Million USD | 4.79% |
| 2023 Q4 | 32.73 Million USD | -1.79% |
| 2023 Q3 | 33.32 Million USD | -15.64% |
| 2022 FY | 161.75 Million USD | 35.75% |
| 2022 Q1 | 36.22 Million USD | -2.91% |
| 2022 Q2 | 40.53 Million USD | 11.91% |
| 2022 Q3 | 40.74 Million USD | 0.53% |
| 2022 Q4 | 44.25 Million USD | 8.62% |
| 2021 FY | 119.15 Million USD | 147.79% |
| 2021 Q3 | 33.8 Million USD | 8.32% |
| 2021 Q2 | 31.2 Million USD | 85.22% |
| 2021 Q4 | 37.3 Million USD | 10.37% |
| 2021 Q1 | 16.84 Million USD | 14.4% |
| 2020 Q1 | 12.16 Million USD | 46.62% |
| 2020 Q3 | 11.27 Million USD | 13.7% |
| 2020 Q4 | 14.72 Million USD | 30.56% |
| 2020 FY | 48.08 Million USD | 75.69% |
| 2020 Q2 | 9.92 Million USD | -18.43% |
| 2019 Q4 | 8.29 Million USD | 25.61% |
| 2019 Q1 | 5.77 Million USD | 5.76% |
| 2019 Q2 | 6.7 Million USD | 16.14% |
| 2019 FY | 27.37 Million USD | 38.64% |
| 2019 Q3 | 6.6 Million USD | -1.45% |
| 2018 Q1 | 3.81 Million USD | 21.73% |
| 2018 FY | 19.74 Million USD | 79.11% |
| 2018 Q4 | 5.45 Million USD | 3.08% |
| 2018 Q3 | 5.29 Million USD | 2.23% |
| 2018 Q2 | 5.17 Million USD | 35.73% |
| 2017 Q1 | 2.36 Million USD | 5.16% |
| 2017 Q2 | 2.55 Million USD | 8.1% |
| 2017 FY | 11.02 Million USD | 33.97% |
| 2017 Q4 | 3.13 Million USD | 5.76% |
| 2017 Q3 | 2.96 Million USD | 15.86% |
| 2016 Q3 | 2.13 Million USD | 7.3% |
| 2016 Q2 | 1.98 Million USD | 7.45% |
| 2016 Q1 | 1.85 Million USD | 1.79% |
| 2016 FY | 8.22 Million USD | 27.57% |
| 2016 Q4 | 2.25 Million USD | 5.38% |
| 2015 Q3 | 1.63 Million USD | 9.03% |
| 2015 Q2 | 1.49 Million USD | -0.26% |
| 2015 Q4 | 1.81 Million USD | 11.49% |
| 2015 FY | 6.44 Million USD | 4.17% |
| 2015 Q1 | 1.5 Million USD | -10.16% |
| 2014 FY | 6.19 Million USD | -30.83% |
| 2014 Q4 | 1.67 Million USD | 34.34% |
| 2014 Q3 | 1.24 Million USD | 2.6% |
| 2014 Q2 | 1.21 Million USD | -41.31% |
| 2014 Q1 | 2.06 Million USD | -9.78% |
| 2013 Q2 | 2.33 Million USD | 7.87% |
| 2013 Q3 | 2.17 Million USD | -6.85% |
| 2013 Q4 | 2.28 Million USD | 5.45% |
| 2013 FY | 8.94 Million USD | 58.03% |
| 2013 Q1 | 2.16 Million USD | 5.46% |
| 2012 Q4 | 2.04 Million USD | 21.81% |
| 2012 Q3 | 1.68 Million USD | 53.22% |
| 2012 Q1 | 835.88 Thousand USD | 3.25% |
| 2012 Q2 | 1.09 Million USD | 31.29% |
| 2012 FY | 5.66 Million USD | 105.28% |
| 2011 Q4 | 809.56 Thousand USD | 13.14% |
| 2011 Q2 | 622.84 Thousand USD | 1.97% |
| 2011 Q1 | 610.79 Thousand USD | 6.04% |
| 2011 Q3 | 715.51 Thousand USD | 14.88% |
| 2011 FY | 2.75 Million USD | 32.53% |
| 2010 FY | 2.08 Million USD | 31.61% |
| 2010 Q4 | 575.99 Thousand USD | 9.74% |
| 2010 Q3 | 524.89 Thousand USD | 12.21% |
| 2010 Q2 | 467.77 Thousand USD | -8.8% |
| 2010 Q1 | 512.9 Thousand USD | 6.72% |
| 2009 Q1 | 377.11 Thousand USD | -10.0% |
| 2009 Q3 | 447.36 Thousand USD | 61.78% |
| 2009 Q2 | 276.52 Thousand USD | -26.67% |
| 2009 Q4 | 480.6 Thousand USD | 7.43% |
| 2009 FY | 1.58 Million USD | 19.59% |
| 2008 FY | 1.32 Million USD | 36.02% |
| 2008 Q2 | 277.96 Thousand USD | -12.49% |
| 2008 Q4 | 419.03 Thousand USD | 36.11% |
| 2008 Q1 | 317.63 Thousand USD | -0.99% |
| 2008 Q3 | 307.87 Thousand USD | 10.76% |
| 2007 Q3 | 240.45 Thousand USD | 18.15% |
| 2007 Q1 | 207.48 Thousand USD | 17.96% |
| 2007 Q2 | 203.51 Thousand USD | -1.91% |
| 2007 Q4 | 320.8 Thousand USD | 33.41% |
| 2007 FY | 972.26 Thousand USD | 61.18% |
| 2006 Q3 | 123.95 Thousand USD | -20.7% |
| 2006 Q4 | 175.9 Thousand USD | 41.91% |
| 2006 FY | 603.21 Thousand USD | -1.87% |
| 2006 Q1 | 147.04 Thousand USD | -26.64% |
| 2006 Q2 | 156.31 Thousand USD | 6.31% |
| 2005 Q1 | 119.7 Thousand USD | -25.85% |
| 2005 Q2 | 134.09 Thousand USD | 12.02% |
| 2005 Q3 | 160.47 Thousand USD | 19.67% |
| 2005 Q4 | 200.45 Thousand USD | 24.91% |
| 2005 FY | 614.71 Thousand USD | -1.91% |
| 2004 Q2 | 146.24 Thousand USD | -10.91% |
| 2004 FY | 626.7 Thousand USD | 3.5% |
| 2004 Q4 | 161.43 Thousand USD | 4.24% |
| 2004 Q3 | 154.87 Thousand USD | 5.9% |
| 2004 Q1 | 164.15 Thousand USD | 82.51% |
| 2003 Q4 | 89.94 Thousand USD | -48.47% |
| 2003 FY | 605.51 Thousand USD | -28.66% |
| 2003 Q1 | 228.28 Thousand USD | -31.24% |
| 2003 Q2 | 112.76 Thousand USD | -50.6% |
| 2003 Q3 | 174.52 Thousand USD | 54.76% |
| 2002 FY | 848.79 Thousand USD | -36.85% |
| 2002 Q1 | 302.58 Thousand USD | -1.63% |
| 2002 Q3 | 138 Thousand USD | 39.23% |
| 2002 Q2 | 99.12 Thousand USD | -67.24% |
| 2002 Q4 | 331.97 Thousand USD | 140.55% |
| 2001 Q1 | 475.94 Thousand USD | 33.44% |
| 2001 FY | 1.34 Million USD | 12.99% |
| 2001 Q4 | 307.59 Thousand USD | 24.39% |
| 2001 Q3 | 247.28 Thousand USD | -21.04% |
| 2001 Q2 | 313.18 Thousand USD | -34.2% |
| 2000 Q1 | 399.15 Thousand USD | -28.72% |
| 2000 Q4 | 356.68 Thousand USD | 78.56% |
| 2000 Q3 | 199.75 Thousand USD | -14.6% |
| 2000 Q2 | 233.9 Thousand USD | -41.4% |
| 2000 FY | 1.18 Million USD | -33.04% |
| 1999 Q1 | 390 Thousand USD | 5.48% |
| 1999 Q3 | 380 Thousand USD | -15.56% |
| 1999 Q4 | 560 Thousand USD | 47.37% |
| 1999 FY | 1.77 Million USD | -25.03% |
| 1999 Q2 | 450 Thousand USD | 15.38% |
| 1998 Q4 | 369.74 Thousand USD | -47.18% |
| 1998 Q1 | 500 Thousand USD | -53.33% |
| 1998 Q2 | 700 Thousand USD | 40.0% |
| 1998 Q3 | 700 Thousand USD | 0.0% |
| 1998 FY | 2.36 Million USD | -33.65% |
| 1997 FY | 3.57 Million USD | 0.0% |
| 1997 Q1 | 1 Million USD | 0.0% |
| 1997 Q3 | 700 Thousand USD | -22.22% |
| 1997 Q4 | 1.07 Million USD | 53.06% |
| 1997 Q2 | 900 Thousand USD | -10.0% |
| 1996 Q3 | 1 Million USD | -12.58% |
| 1996 Q1 | 2 Million USD | 17.65% |
| 1996 Q2 | 1.14 Million USD | -42.8% |
| 1996 FY | - USD | -100.0% |
| 1995 Q3 | 2 Million USD | -25.77% |
| 1995 FY | 13.59 Million USD | 1.45% |
| 1995 Q1 | 3 Million USD | -34.78% |
| 1995 Q4 | 1.7 Million USD | -15.0% |
| 1995 Q2 | 2.69 Million USD | -10.19% |
| 1994 Q2 | 3.5 Million USD | 25.0% |
| 1994 Q3 | 3.3 Million USD | -5.71% |
| 1994 Q1 | 2.8 Million USD | -24.32% |
| 1994 FY | 13.4 Million USD | 127.12% |
| 1994 Q4 | 4.6 Million USD | 39.39% |
| 1993 FY | 5.9 Million USD | 5800.0% |
| 1993 Q4 | 3.7 Million USD | 8.82% |
| 1993 Q3 | 3.4 Million USD | 6.25% |
| 1993 Q2 | 3.2 Million USD | 100.0% |
| 1993 Q1 | 1.6 Million USD | 128.57% |
| 1992 Q2 | - USD | -100.0% |
| 1992 FY | 100 Thousand USD | 0.0% |
| 1992 Q4 | 700 Thousand USD | 75.0% |
| 1992 Q3 | 400 Thousand USD | 0.0% |
| 1992 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q4 | 100 Thousand USD | 0.0% |
| 1991 FY | 100 Thousand USD | 0.0% |
| 1991 Q2 | - USD | -100.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q4 | 100 Thousand USD | 0.0% |
| 1990 Q1 | 100 Thousand USD | 0.0% |
| 1990 FY | 100 Thousand USD | 0.0% |
| 1990 Q2 | - USD | -100.0% |
| 1989 Q1 | 100 Thousand USD | 0.0% |
| 1989 FY | 100 Thousand USD | 0.0% |
| 1989 Q4 | 100 Thousand USD | 0.0% |
| 1989 Q3 | 100 Thousand USD | 0.0% |
| 1989 Q2 | - USD | -100.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -48.263% |
| AngioDynamics, Inc. | 303.91 Million USD | 52.858% |
| AtriCure, Inc. | 399.24 Million USD | 64.115% |
| Avinger, Inc. | 7.65 Million USD | -1772.334% |
| Azenta, Inc. | 665.07 Million USD | 78.458% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 96.013% |
| Daxor Corporation | 1.28 Million USD | -11088.545% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -683.801% |
| Femasys Inc. | 1.07 Million USD | -13265.206% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -27.636% |
| Hologic, Inc. | 4.03 Billion USD | 96.445% |
| ICU Medical, Inc. | 2.25 Billion USD | 93.658% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 97.989% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -402.394% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 25.952% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -12331.55% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -12331.55% |
| Masimo Corporation | 2.04 Billion USD | 93.005% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -47.552% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 88.605% |
| Nephros, Inc. | 14.23 Million USD | -906.258% |
| NovoCure Limited | 509.33 Million USD | 71.871% |
| NEXGEL, Inc. | 4.08 Million USD | -3403.815% |
| NEXGEL, Inc. | 4.08 Million USD | -3403.815% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -4821.711% |
| OraSure Technologies, Inc. | 405.47 Million USD | 64.666% |
| Pro-Dex, Inc. | 53.84 Million USD | -166.085% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -7948.512% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -649.939% |
| QuidelOrtho Corporation | 2.99 Billion USD | 95.221% |
| Repligen Corporation | 638.76 Million USD | 77.571% |
| Sanara MedTech Inc. | 64.98 Million USD | -120.451% |
| STAAR Surgical Company | 322.41 Million USD | 55.563% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -185.264% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 96.387% |
| Jin Medical International Ltd. | 19.82 Million USD | -622.808% |